Tuesday, 27 November 2018

Nifty, Sensex Log More Gains – Tuesday closing report-The Total Investment & Insurance Solutions


Contact Your Financial Adviser Money Making MC
27 November 2018

I had mentioned in Monday’s closing report that Nifty, Sensex were headed higher. The major indices of the Indian stock markets rallied, after a dip, on Tuesday and closed with gains over Monday’s close. On the NSE, there were 792 advances, 921 declines and 342 unchanged. The trends of the major indices in the course of Tuesday’s trading are given in the table below:


The key equity indices were higher on Tuesday, but banking stocks were subdued. Buying was witnessed in energy and IT (information technology) stocks. On Monday, the Centre's recapitalization announcement of Rs42,000 crore to unhealthy PSU (public sector undertakings) banks boosted investor sentiments. Currently, 11 of the 21 state-run banks are under RBI's (Reserve Bank of India) Prompt corrective action (PCA) framework which restricts weak banks from carrying out certain operations. 

Crude oil prices traded at $60.15 per barrel while the domestic currency was nearly flat at Rs70.90 per dollar from its previous close of 70.87. The decline in crude oil prices, which has crashed over 30% since early October, comes amid expectations of slowing demand and an over-supplied crude oil market led by the US. The Indian rupee, as a consequence, has gained over 5% against the US dollar from its life time high of 74.47.

Ahead of the official release of the second-quarter GDP figures, State Bank of India (SBI) estimated the country's economy to expand by 7.5%-7.6%, slower than the prior quarter, mainly on account of a slowdown in rural demand. 

Granules India has received USFDA (Food and Drug Administration) approval for its ANDA for Methylphenidate Hydrochloride Extended-Release Tablets USP. The approved ANDA is therapeutically equivalent to the RLD - Ritalin SR Sustained-Release Tablets of Novartis Pharmaceuticals. Granules India shares closed at Rs87.90, down 2.93% on the NSE.

Alembic Pharmaceuticals has received approval from the USFDA for its ANDA Temazepam Capsules USP, therapeutically equivalent to RLD, Restoril Capsules of SpecGx LLC. Temazepam Capsules are indicated for short term treatment of insomnia. The company’s shares closed at Rs561.05, down 0.21% on the NSE.

IIFL Holdings reported that IIFL Securities was to acquire 15% strategic stake in Bangalore based fin-tech startup 'Trendlyne' (Giskard Datatech Private Ltd), a stock market analytics platform for retail investors, analysts, fund managers and advisors. IIFL Holdings shares closed at Rs477.00, down 0.02% on the NSE.

Graphite electrodes manufacturer HEG's board has approved a buyback of 3.41% of the company's equity shares worth Rs750 crore. The firm has set the buyback price at Rs5,500 per equity share. In addition, HEG also announced an expansion of its graphite electrode capacity to 100,000 TPA (tonnes per annum) from 80,000 TPA. "The additional 20,000 TPA will be at the cost of 1,200 crore rupee and is likely to be financed via internal accruals and debt, if required. The fresh capacity is likely to come on stream within 30-36 months." HEG is currently operating at a capacity of 85%-90%. HEG shares closed at Rs4,350.00, down 0.18% on the NSE.

The top gainers and top losers of the major indices are given in the table below:


The closing values of the major Asian indices are given in the table below: The Total Investment & Insurance Solutions

Major Indices (The Total Investment & Insurance Solutions)



No comments:

Post a Comment